News

Patients who survive a heart attack together with sudden cardiac arrest are at increased risk of dying within six years following hospital discharge.

Diagnosing heart attacks after heart surgery remains difficult due to shortcomings of current diagnostic tools when applied to postoperative patients, including the electrocardiogram and blood tests to detect levels of cardiac troponins,...

BIOTRONIK Sets New Clinical Benchmark with Ultrathin Strut Orsiro Coronary Drug-Eluting Stent

Boston Scientific announced positive results from a new analysis assessing real-world outcomes with the WATCHMAN FLX™ Left Atrial Appendage Closure (LAAC) Device.

Degree equips students with vital skills in cardiac interventional technologies, cardiac rhythm management, and electrophysiology.

Cardiovascular Institute of the South interventional cardiologist Dr. Niksad Abraham is the first in the Capital Region to use the Inari Medical FlowTriever® System for the treatment of a clot-in-transit in the right atrium of the heart

The U.S. Food and Drug Administration approved Jardiance (empagliflozin) to reduce the risk of cardiovascular death and hospitalization for heart failure in adults.

Wellesley College researchers find that when people are asked to indicate where they think the data in a bar graph lie, 1 in 5 make a fundamental error.

Patients with both a high lipoprotein(a) and high coronary artery calcium score (CAC) face a more than 20% risk of heart attack or stroke over the following 10 years.

Physician-scientists in the Smidt Heart Institute at Cedars-Sinai have created an artificial intelligence (AI) tool that can effectively identify and distinguish between two life-threatening heart conditions that are often easy to miss:...